公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2021 | Long-Term Overall Survival From KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin With or Without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous NSCLC | Awad M.M.; Gadgeel S.M.; Borghaei H.; Patnaik A.; CHIH-HSIN YANG ; Powell S.F.; Gentzler R.D.; Martins R.G.; Stevenson J.P.; Altan M.; Jalal S.I.; Panwalkar A.; Gubens M.; Sequist L.V.; Saraf S.; Zhao B.; Piperdi B.; Langer C.J. | Journal of Thoracic Oncology | 94 | 77 | |
2017 | Outcomes in Transcatheter Aortic Valve Replacement for Bicuspid Versus Tricuspid Aortic Valve Stenosis | Yoon S.-H.; Bleiziffer S.; De Backer O.; Delgado V.; Arai T.; Ziegelmueller J.; Barbanti M.; Sharma R.; Perlman G.Y.; Khalique O.K.; Holy E.W.; Saraf S.; Deuschl F.; Fujita B.; Ruile P.; Neumann F.-J.; Pache G.; Takahashi M.; Kaneko H.; Schmidt T.; Ohno Y.; Schofer N.; Kong W.K.F.; Tay E.; Sugiyama D.; Kawamori H.; Maeno Y.; Abramowitz Y.; Chakravarty T.; Nakamura M.; Kuwata S.; Yong G.; HSIEN-LI KAO ; Lee M.; Kim H.-S.; Modine T.; Wong S.C.; Bedgoni F.; Testa L.; Teiger E.; Butter C.; Ensminger S.M.; Schaefer U.; Dvir D.; Blanke P.; Leipsic J.; Nietlispach F.; Abdel-Wahab M.; Chevalier B.; Tamburino C.; Hildick-Smith D.; Whisenant B.K.; Park S.-J.; Colombo A.; Latib A.; Kodali S.K.; Bax J.J.; Søndergaard L; Webb J.G.; Lefèvre T.; Leon M.B.; Makkar R. | Journal of the American College of Cardiology | 334 | 300 | |
2018 | Pembrolizumab for the treatment of advanced salivary gland carcinoma | Cohen R.B.; Delord J.-P.; Doi T.; Piha-Paul S.A.; Liu S.V.; Gilbert J.; Algazi A.P.; Damian S.; RUEY-LONG HONG ; Le Tourneau C.; Day D.; Varga A.; Elez E.; Wallmark J.; Saraf S.; Thanigaimani P.; Cheng J.; Keam B. | American Journal of Clinical Oncology: Cancer Clinical Trials | 151 | 119 | |
2017 | Safety and antitumor activity of pembrolizumab in patients with programmed death-ligand 1-positive nasopharyngeal carcinoma: Results of the KEYnote-028 study | CHIUN HSU ; Lee S.-H.; Ejadi S.; Even C.; Cohen R.B.; Le Tourneau C.; Mehnert J.M.; Algazi A.; Van Brummelen E.M.J.; Saraf S.; Thanigaimani P.; Cheng J.D.; Hansen A.R. | Journal of Clinical Oncology | 315 | 280 | |
2019 | Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced, PD-L1-positive papillary or follicular thyroid cancer | Mehnert J.M.; Varga A.; Brose M.S.; Aggarwal R.R.; CHIA-CHI LIN ; Prawira A.; De Braud F.; Tamura K.; Doi T.; Piha-Paul S.A.; Gilbert J.; Saraf S.; Thanigaimani P.; Cheng J.D.; Keam B. | BMC Cancer | 133 | 108 |